All stocks
$ 140.50 ARS-2.43%LAST CLOSE · ARS · Oct 02, 2026

A veterinary laboratory producing biologicals and medicines for animal health.

Market capitalisation≈ 5.98B ARSMarket value of the company’s shares
Price / earnings (P/E)Not availablePrice relative to 12-month earnings
Forward P/ENot availablePrice relative to forecast earnings
Dividend yield0%Dividends relative to the share price
LAST CLOSE · ARS

$ 140.50

-9.65%over 1M · Oct 02, 2026
Price history
Source: BYMA Open Data · Daily bars · T+1 settlement

Price data table

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · BYMA · ARS · 1M
DateOpenHighLowCloseVolume
144144140140.534,430
150150143144129,800
14214914214911,382
149150145.5145.511,660
1431481431486,385
1501501471472,624
150.5150.5147.5148.53,840
156.5156.5154.5154.5524
154.5154.51541543,227
146157.5145152.517,643
146153145149.516,583
150155.515015028,972
1531531531531,500
153.5158152.515512,950
154156149152.547,647
154.5157154.51575,158
154.5157154.51558,234
153.51541531546,213
1601601521544,267
161.5161.5156.5156.52,611
16016515615712,828
153160150157.525,840
1531591501568,828
158162.5151155.52,765

Daily BYMA observations for the selected period, newest first. Prices are in ARS. “—” means missing data; zeros are retained even when not plotted. Dates use Buenos Aires time.

The business

Instituto Rosenbusch develops veterinary products, including biologicals and medicines for animal health. Buyers need prevention and treatment suited to species and production systems. The laboratory turns expertise, inputs and controlled processes into products; batch quality and storage are part of delivery.

Latest fiscal year

Fiscal year 2025Period end:

Revenue
≈ 6.4B ARS
Net income
≈ -4.6B ARS
Total assets
≈ 7.75B ARS
Total debt
≈ 1.45B ARS
THE BUSINESS, EXPLAINED

About Instituto Rosenbusch

A veterinary laboratory producing biologicals and medicines for animal health.

Instituto Rosenbusch works in animal health through biological and pharmaceutical products. Its offering addresses veterinary needs; each product’s use depends on its approval and indications.

Exchange
BYMA
Local symbol
ROSE
Business areas
1

Business economics · explained by La Plata

Customers, operations & revenue

Instituto Rosenbusch develops veterinary products, including biologicals and medicines for animal health. Buyers need prevention and treatment suited to species and production systems. The laboratory turns expertise, inputs and controlled processes into products; batch quality and storage are part of delivery.

What shapes business performance

Demand relates to animal health and livestock activity, rather than human consumption alone. Product registration, quality control, expiry and stock require resources. Sales volumes, treatment mix and production costs explain margins without assigning undisclosed contributions to individual products.

Products, services & businesses

Animal health

Instituto Rosenbusch develops biological and pharmaceutical products for animal health. The portfolio supports veterinary prevention and treatment; manufacturing, storage and distribution must preserve product requirements, with use governed by approved indications.

Who it serves
Professionals, distributors and institutions in human or animal health, depending on the product.
How the business works
Development and manufacturing must meet technical and approval requirements. Commercial activity combines a product portfolio, distribution channels and production capacity.

The business in practice

Selected products, companies and assets from corporate publications.

Veterinary products and sales markets

The June 2026 report describes biological, chemical and pharmaceutical manufacturing focused on veterinary and agricultural uses, and separates domestic and export sales. It shows Rosenbusch as a manufacturer serving several markets; production, inventories and sales collection are distinct parts of its cycle.

Rosenbusch · June 2026 reportConsulted

Corporate information: Instituto RosenbuschSources consulted Text & translation: La Plata · AI assisted

Financials

Revenue and expenses, assets and liabilities, cash coming in and going out. Choose a statement and the period you want to explore.

Income statement

Income statement

Fiscal year 2025Period end:

ARS
Revenue
≈ 6.4B ARS6,403,594,170 ARS
Net revenue
—
Gross profit
≈ -609.92M ARS-609,923,024 ARS
Operating income
≈ -3.17B ARS-3,173,180,353 ARS
EBITDA
≈ -2.98B ARS-2,981,564,120 ARS
EBIT
—
Net income
≈ -4.6B ARS-4,597,736,040 ARS
Diluted EPS
≈ -107.95 ARS-107.9548 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Income statement · ARS
Indicator20252024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue≈ 6.4B6,403,594,170≈ 8.27B8,274,920,184.000001≈ 4.53B4,528,054,700≈ 1.37B1,373,063,089≈ 781.61M781,605,341≈ 558.63M558,625,701≈ 411.82M411,817,052≈ 298.92M298,918,700≈ 172.14M172,138,444≈ 167.31M167,306,023≈ 135.49M135,492,939≈ 107.66M107,662,641≈ 85.19M85,185,390≈ 82.86M82,862,652≈ 71.95M71,952,103≈ 56.88M56,880,189≈ 58.98M58,976,528≈ 53.09M53,091,613≈ 75.36M75,358,258≈ 67.05M67,047,697
Gross profit≈ -609.92M-609,923,024≈ 3.8B3,801,288,943≈ 1.32B1,322,074,316≈ 636.03M636,031,710≈ 219.51M219,509,674≈ 187.37M187,370,422≈ 133.98M133,976,056≈ 80.46M80,457,039≈ 56.26M56,255,158≈ 59.84M59,838,601≈ 36.73M36,732,479≈ 31.99M31,986,401≈ 27.65M27,652,976≈ 27.36M27,364,732≈ 27.94M27,941,065≈ 20.34M20,340,915≈ 14.29M14,293,489≈ 13.41M13,413,377≈ 17.09M17,089,215≈ 17.22M17,223,882
EBITDA≈ -2.98B-2,981,564,120≈ 2.04B2,042,886,490≈ 177.99M177,989,480≈ 336.3M336,303,310≈ 31.45M31,448,640≈ 51.84M51,842,580≈ -9.26M-9,264,480≈ 8.61M8,613,180≈ 3.27M3,271,500≈ 17.87M17,865,310627,540≈ 5.65M5,645,540≈ 7.28M7,276,380≈ 9.21M9,205,240≈ 11.62M11,620,060≈ 4.73M4,729,800837,650361,510≈ 4.37M4,373,620≈ 8.55M8,547,680
Net income≈ -4.6B-4,597,736,040≈ -1.42B-1,417,322,392≈ 562.94M562,940,954≈ -8.1M-8,097,740.999999999≈ -19.57M-19,571,726≈ -17.01M-17,005,406≈ -89.2M-89,204,196798,264-72,315≈ 10.16M10,162,704-727,460≈ 8.35M8,346,227.000000001≈ -9.12M-9,120,272≈ 9.28M9,284,004≈ 6.96M6,956,817≈ 2.95M2,950,858982,002≈ -1.37M-1,367,615≈ 1.78M1,779,935≈ 4.1M4,099,993.0000000005
Basic EPSARS · per share≈ -107.95-107.9548≈ -33.28-33.2787≈ 13.2213.2178≈ -0.19-0.1901≈ -0.46-0.4595≈ -0.399-0.3993≈ -2.09-2.09450.0187-0.0020.239-0.0170.2-0.2150.2190.160.06960.023-0.0320.0466≈ 0.1040.1044
Diluted EPSARS · per share≈ -107.95-107.9548≈ -33.28-33.2787≈ 13.2213.2178≈ -0.19-0.1901≈ -0.46-0.4595≈ -0.399-0.3993≈ -2.09-2.09450.0187-0.0020.239-0.0170.2-0.2150.2190.16—————

Income statement

Income statement

Quarter 2 · fiscal 2026Period end:

ARS
Revenue
≈ 2.18B ARS2,181,083,409 ARS
Net revenue
—
Gross profit
≈ 66.86M ARS66,855,941 ARS
Operating income
≈ -630.74M ARS-630,744,812 ARS
EBITDA
≈ -607.55M ARS-607,551,340 ARS
EBIT
—
Net income
≈ 2.79B ARS2,788,161,200 ARS
Diluted EPS
≈ 65.47 ARS65.466 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Income statement

Income statement

Trailing 12 monthsPeriod-end date not specified

ARS
Revenue
≈ 7.66B ARS7,660,154,095 ARS
Net revenue
—
Gross profit
≈ -328.86M ARS-328,857,952 ARS
Operating income
≈ -3.41B ARS-3,407,716,551 ARS
EBITDA
≈ -3.26B ARS-3,255,151,380 ARS
EBIT
≈ -3.41B ARS-3,407,716,550 ARS
Net income
≈ -435.38M ARS-435,379,731 ARS
Diluted EPS
≈ -10.22 ARS-10.2227 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Balance sheet

Balance sheet

Fiscal year 2025Period end:

ARS
Total assets
≈ 7.75B ARS7,745,454,535 ARS
Total liabilities
≈ 8.27B ARS8,271,645,463.999999 ARS
Total equity
≈ -526.19M ARS-526,190,929 ARS
Total debt
≈ 1.45B ARS1,450,004,478 ARS
Cash & equivalents
≈ 712.26M ARS712,263,697 ARS
Cash & short-term investments
≈ 712.26M ARS712,263,697 ARS
Net debt
≈ 737.74M ARS737,740,781 ARS
Current assets
≈ 5.73B ARS5,732,979,805 ARS
Current liabilities
≈ 6.61B ARS6,605,344,948 ARS
Goodwill
0 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Balance sheet · ARS
Indicator20252024202320222021202020192018201720162015201420132012201120102009200820072006
Total assets≈ 7.75B7,745,454,535≈ 7.54B7,542,016,849≈ 5.04B5,042,761,206≈ 1.35B1,347,992,247≈ 747.29M747,291,579≈ 675.64M675,640,386≈ 496.94M496,938,633≈ 366.76M366,755,730≈ 213.52M213,524,591≈ 197.86M197,856,838≈ 166.17M166,170,337≈ 140.76M140,755,331≈ 125.89M125,888,965≈ 114.9M114,898,394≈ 86.45M86,445,777≈ 73.43M73,425,376≈ 64.48M64,482,445≈ 57.44M57,441,037≈ 53.83M53,829,858≈ 48.52M48,519,748
Total debt≈ 1.45B1,450,004,478≈ 1.74B1,740,294,248≈ 1.03B1,033,846,858.0000001≈ 344.94M344,938,917≈ 190.98M190,975,143≈ 155.12M155,124,786≈ 125.07M125,067,925≈ 93.84M93,837,234≈ 42.83M42,832,357≈ 32.66M32,661,935.999999996≈ 34.12M34,121,149≈ 20.37M20,368,077≈ 23.34M23,338,384≈ 21.39M21,390,455≈ 1.04M1,040,840467,394730,847346,023≈ 3.41M3,406,283350,312

Balance sheet

Balance sheet

Quarter 2 · fiscal 2026Period end:

ARS
Total assets
≈ 22.67B ARS22,666,208,558 ARS
Total liabilities
≈ 14.73B ARS14,734,353,625 ARS
Total equity
≈ 7.93B ARS7,931,854,933 ARS
Total debt
≈ 3.07B ARS3,067,876,474 ARS
Cash & equivalents
≈ 986.43M ARS986,430,848 ARS
Cash & short-term investments
≈ 986.43M ARS986,430,848 ARS
Net debt
≈ 2.08B ARS2,081,445,626.0000002 ARS
Current assets
≈ 8.01B ARS8,010,019,676 ARS
Current liabilities
≈ 4.47B ARS4,471,936,871 ARS
Goodwill
0 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Cash flow

Cash flow

Fiscal year 2025Period end:

ARS
Operating cash flow
≈ 409.89M ARS409,886,740 ARS
Investing cash flow
≈ -12.13M ARS-12,134,976 ARS
Financing cash flow
≈ -839.33M ARS-839,331,035 ARS
Capital expenditure · source sign
≈ -12.13M ARS-12,134,976 ARS
Free cash flow
≈ 397.75M ARS397,751,760 ARS
Dividends paid · source sign
-0 ARS

Figures for the stated period. “—” means no data is available.

Each column is a fiscal year. “—” means no data is available.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Cash flow · ARS
Indicator20252024202320222021202020192018201720162015201420132012201120102009200820072006
Free cash flow≈ 397.75M397,751,760≈ 537.19M537,190,060≈ 99.16M99,155,570≈ 22.72M22,715,500≈ 27.82M27,823,020≈ 41.51M41,505,640≈ 12.05M12,051,470≈ -23.57M-23,565,030≈ -10.99M-10,987,41083,240≈ -11.25M-11,247,380≈ 5.04M5,043,730≈ -11.55M-11,550,050≈ -12.98M-12,983,660≈ 1.01M1,007,960≈ 1.33M1,331,420≈ -3.71M-3,711,980≈ 5.62M5,616,080≈ -1.19M-1,192,900≈ -2.07M-2,073,080

Cash flow

Cash flow

Quarter 2 · fiscal 2026Period end:

ARS
Operating cash flow
≈ 1.17B ARS1,170,481,414 ARS
Investing cash flow
≈ 127.17M ARS127,172,816 ARS
Financing cash flow
≈ -522.3M ARS-522,298,791.00000006 ARS
Capital expenditure · source sign
-0 ARS
Free cash flow
—
Dividends paid · source sign
-0 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Cash flow

Cash flow

Trailing 12 monthsPeriod-end date not specified

ARS
Operating cash flow
≈ 867.08M ARS867,084,615 ARS
Investing cash flow
≈ 125.72M ARS125,717,247 ARS
Financing cash flow
≈ -1.26B ARS-1,262,503,716 ARS
Capital expenditure · source sign
-0 ARS
Free cash flow
—
Dividends paid · source sign
-0 ARS

Figures for the stated period. “—” means no data is available.

More figures and histories under “Key metrics”.

Short figures; ≈ indicates rounding.All available digits, without rounding.

Business performance

2006–2025 · ARS · Fiscal years

View performance

Annual results table

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

Revenue, Net income · ARS · 2006–2025
Fiscal yearRevenueNet income
20256,403,594,170-4,597,736,040
20248,274,920,184.000001-1,417,322,392
20234,528,054,700562,940,954
20221,373,063,089-8,097,740.999999999
2021781,605,341-19,571,726
2020558,625,701-17,005,406
2019411,817,052-89,204,196
2018298,918,700798,264
2017172,138,444-72,315
2016167,306,02310,162,704
2015135,492,939-727,460
2014107,662,6418,346,227.000000001
201385,185,390-9,120,272
201282,862,6529,284,004
201171,952,1036,956,817
201056,880,1892,950,858
200958,976,528982,002
200853,091,613-1,367,615
200775,358,2581,779,935
200667,047,6974,099,993.0000000005

Provider-reported annual values, newest first, without compacting numbers or filling missing periods. “—” means missing data, not zero.

Provider-reported historical figures may reflect different inflation adjustment bases. They are not recalculated or restated here.

Financial dataUpdated: Oct 03, 2026 · ARS

Valuation

P/E, forward P/E and other multiples relate equity or enterprise value to results and resources. Read them alongside profitability, debt and dividends, keeping reported figures distinct from estimates.

Valuation

Market capitalisation
≈ 5.98B ARS
Enterprise value · current
≈ 8.33B ARS
P/E · TTM
—
Forward P/E
—
P/E · next FY · non-GAAP
—
P/B · latest quarter
≈ 0.78×
PEG · TTM
—
P/Free cash flow · TTM
—
Forward P/B
—
P/S · TTM
≈ 0.781×
Forward P/S
—
EV/EBITDA · TTM
—
Forward EV/EBITDA
—
EV/EBIT · TTM
—
EV/Revenue · TTM
≈ 1.09×
P/Operating cash flow · TTM
≈ 6.9×
Earnings yield
≈ -7.28%

Multiples may use a price different from the BYMA close. Forward P/E and next-year non-GAAP P/E are separate series.

Financial dataUpdated: Oct 03, 2026 · ARS

Dividends

Dividends per share, payment dates and yield. Reported amounts and estimates are identified separately.

Dividends

Dividend yield · current
0%
Payout ratio · TTM
-0%
Latest dividend per share
—
Ex-dividend date
—
Payment date
—
Estimated dividend per share · FY
—

Dividend-per-share history

View history
Financial dataUpdated: Oct 03, 2026 · ARS

Forecasts

Forecasts collect revenue and earnings estimates where available for this instrument. Check each figure’s forecast horizon and the publication history before comparing it with the company’s results.

Estimates, not reported results. NTM: next 12 months; next FY: following fiscal year. Individual estimate dates are unavailable.

Analyst estimates

EPS estimate · next 12 months
—
Revenue estimate · next 12 months
—
Net income estimate · next 12 months
—
EPS forecast · next FY
—
Revenue forecast · next FY
—
Average price target
—
Median price target
—
Lowest price target
—
Highest price target
—
Analysts with recommendations
—
Buy
—
Outperform
—
Hold
—
Underperform
—
Sell
—
Financial dataUpdated: Oct 03, 2026 · ARS

Shareholders

Ownership structure helps explain economic interests and control. Equity holdings and voting rights are shown separately, with the date and scope of verified information.

As of Feb 10, 2026 · Retrieved Sep 29, 2026

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Shareholders · %
Shareholder / groupCapitalVoting rights
Agro 2000 S.A.80.16%—

Capital ownership and voting rights are different measures. “—” means unavailable, not zero.

Partial coverage: only confirmed holdings are shown.

ROSE · Company metrics

What would you like to explore?

Explore the company, one topic at a time.

All metric groups

Filters & format

Period
Show

≈ indicates a rounded or abbreviated number. Enable “Exact values” to see all available digits.All available digits are shown without rounding. Downloads always retain the original values.

View results

Periods and units are identified when confirmed.

All metric groups

Valuation

Valuation
Market capitalisation≈ 5.98B ARS5,982,969,410 ARSPeriod not specified
Price / earnings (P/E)Not availableLast 12 months
Price / book value (P/B)≈ 0.78×0.7801901231706416×Quarter

How to read this group

Compare multiples on the same currency and period basis. P/E uses earnings; forward P/E uses estimates.

Definitions in the guide
ROSE · Valuation
IndicatorIndicator and periodPeriodValue
Market capitalisationPeriod not specifiedPeriod not specified≈ 5.98B ARS5,982,969,410 ARS
Enterprise value (EV)Latest available figureLatest available figure≈ 8.33B ARS8,326,575,540 ARS
Enterprise value (EV)QuarterQuarter≈ 9.29B ARS9,285,688,925 ARS
Price / book value (P/B)Latest available figureLatest available figure≈ 0.808×0.8079548962372125×
Price / book value (P/B)QuarterQuarter≈ 0.78×0.7801901231706416×
Price / sales (P/S)Latest available figureLatest available figure≈ 0.809×0.8089611619621098×
Price / sales (P/S)Reported figure 1Period not specifiedPeriod not specified≈ 0.934×0.9343140026001991×
Earnings yieldPeriod not specifiedPeriod not specified≈ -7.28%-7.2759430604982205%
EV/Revenue · TTMLast 12 monthsLast 12 months≈ 1.09×1.0869984385085663×
P/Operating cash flow · TTMLast 12 monthsLast 12 months≈ 6.9×6.901079466736935×
P/S · annual basisPeriod not specifiedPeriod not specified≈ 0.968×0.9677014178273602×
P/S · TTMLast 12 monthsLast 12 months≈ 0.781×0.7811618093173637×
Price / book value (P/B)Period not specifiedPeriod not specified≈ -7.48×-7.478205422311026×
Price / cashPeriod not specifiedPeriod not specified≈ 6.07×6.066132101030969×
Price / cash flowLatest available figureLatest available figure≈ 7.15×7.146669483346801×
Price / sales (P/S)Reported figure 2Period not specifiedPeriod not specified≈ 0.934×0.9344470735721244×
Price / working capitalQuarterQuarter≈ 1.69×1.6912605391947575×
Tobin’s Q · approximationFinancial yearFinancial year≈ 1.32×1.322422885088951×
Tobin’s Q · approximationQuarterQuarter≈ 0.306×0.3062745486187545×

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Revenue & earnings

Revenue & earnings
Revenue≈ 6.4B ARS6,403,594,170 ARSFiscal year 2025Period end:
Operating income≈ -3.17B ARS-3,173,180,353 ARSFiscal year 2025Period end:
Net income≈ -4.6B ARS-4,597,736,040 ARSFiscal year 2025Period end:

How to read this group

Revenue, profit and cash generation describe different things. Read them alongside margins and operating cash flow.

Definitions in the guide
ROSE · Revenue & earnings
IndicatorIndicator and periodPeriodValue
RevenueLast 12 monthsLast 12 months≈ 7.66B ARS7,660,154,095 ARS
RevenueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 6.4B ARS6,403,594,170 ARS
RevenueQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.18B ARS2,181,083,409 ARS
RevenueHalf-yearHalf-year≈ 3.78B ARS3,782,559,075 ARS
RevenuePeriod not specifiedPeriod not specified≈ 6.4B ARS6,403,594,170 ARS
Gross profitLast 12 monthsLast 12 months≈ -328.86M ARS-328,857,952 ARS
Gross profitFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -609.92M ARS-609,923,024 ARS
Gross profitQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 66.86M ARS66,855,941 ARS
Gross profitHalf-yearHalf-year≈ -194.65M ARS-194,649,373 ARS
Gross profitPeriod not specifiedPeriod not specified≈ -609.92M ARS-609,923,024 ARS
Operating incomeLast 12 monthsLast 12 months≈ -3.41B ARS-3,407,716,551 ARS
Operating incomeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -3.17B ARS-3,173,180,353 ARS
Operating incomeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -630.74M ARS-630,744,812 ARS
Operating incomeHalf-yearHalf-year≈ -1.59B ARS-1,592,062,560 ARS
EBITDALast 12 monthsLast 12 months≈ -3.26B ARS-3,255,151,380 ARS
EBITDAFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -2.98B ARS-2,981,564,120 ARS
EBITDAQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -607.55M ARS-607,551,340 ARS
EBITDAHalf-yearHalf-year≈ -1.54B ARS-1,544,427,540 ARS
EBITDAPeriod not specifiedPeriod not specified≈ -3.26B ARS-3,255,151,380 ARS
EBITLast 12 monthsLast 12 months≈ -3.41B ARS-3,407,716,550 ARS
Net incomeLast 12 monthsLast 12 months≈ -435.38M ARS-435,379,731 ARS
Net incomeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -4.6B ARS-4,597,736,040 ARS
Net incomeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.79B ARS2,788,161,200 ARS
Net incomeHalf-yearHalf-year≈ 2.3B ARS2,304,556,481 ARS
Net incomePeriod not specifiedPeriod not specified≈ -4.6B ARS-4,597,736,040 ARS
Basic EPSLast 12 monthsLast 12 months≈ -10.22 ARS-10.2227 ARS
Basic EPSFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -107.95 ARS-107.9548 ARS
Basic EPSQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 65.47 ARS65.466 ARS
Basic EPSHalf-yearHalf-year≈ 54.11 ARS54.11099999999999 ARS
Diluted EPSLast 12 monthsLast 12 months≈ -10.22 ARS-10.2227 ARS
Diluted EPSFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -107.95 ARS-107.9548 ARS
Diluted EPSQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 65.47 ARS65.466 ARS
Diluted EPSHalf-yearHalf-year≈ 54.11 ARS54.11099999999999 ARS
EBIT per shareLatest available figureLatest available figure≈ -80.01 ARS-80.01313352961819 ARS
EBIT per shareLast 12 monthsLast 12 months≈ -80.01 ARS-80.01313352961819 ARS
EBIT per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -74.51 ARS-74.5062270681259 ARS
EBIT per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -14.81 ARS-14.8098786871354 ARS
EBITDA per shareLatest available figureLatest available figure≈ -76.43 ARS-76.43090562419603 ARS
EBITDA per shareLast 12 monthsLast 12 months≈ -76.43 ARS-76.43090562419603 ARS
EBITDA per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -70.01 ARS-70.007080859081 ARS
EBITDA per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -14.27 ARS-14.265296359087865 ARS
Net income before discontinued operationsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -4.6B ARS-4,597,736,040 ARS
Revenue per shareLatest available figureLatest available figure≈ 179.86 ARS179.860303363754 ARS
Revenue per shareLast 12 monthsLast 12 months≈ 179.86 ARS179.860303363754 ARS
Revenue per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 150.36 ARS150.356295154212 ARS
Revenue per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 51.21 ARS51.2118057599456 ARS

Choose an indicator to explore its history.

Financial year

Basic EPS

Earnings attributable to each ordinary share, using the average share count for the period. It is not the dividend.

Revenue & earnings

RevenueLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Revenue · ARS
Position in seriesValue · ARS
1≈ 7.66B ARS7,660,154,095 ARS
2≈ 6.89B ARS6,888,263,122 ARS
3≈ 6.4B ARS6,403,594,170 ARS
4≈ 6.09B ARS6,092,723,201 ARS
5≈ 6.64B ARS6,644,405,458 ARS
6≈ 7.43B ARS7,432,110,498 ARS
7≈ 8.27B ARS8,274,920,184.000001 ARS
8≈ 9.14B ARS9,143,529,173 ARS
Revenue & earnings

RevenueFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Revenue
RevenueARS
2025≈ 6.4B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Revenue · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 6.4B ARS6,403,594,170 ARS
2024≈ 8.27B ARS8,274,920,184.000001 ARS
2023≈ 4.53B ARS4,528,054,700 ARS
2022≈ 1.37B ARS1,373,063,089 ARS
2021≈ 781.61M ARS781,605,341 ARS
2020≈ 558.63M ARS558,625,701 ARS
2019≈ 411.82M ARS411,817,052 ARS
2018≈ 298.92M ARS298,918,700 ARS
2017≈ 172.14M ARS172,138,444 ARS
2016≈ 167.31M ARS167,306,023 ARS
2015≈ 135.49M ARS135,492,939 ARS
2014≈ 107.66M ARS107,662,641 ARS
2013≈ 85.19M ARS85,185,390 ARS
2012≈ 82.86M ARS82,862,652 ARS
2011≈ 71.95M ARS71,952,103 ARS
2010≈ 56.88M ARS56,880,189 ARS
2009≈ 58.98M ARS58,976,528 ARS
2008≈ 53.09M ARS53,091,613 ARS
2007≈ 75.36M ARS75,358,258 ARS
2006≈ 67.05M ARS67,047,697 ARS
Revenue & earnings

RevenueQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Revenue · ARS
Position in seriesValue · ARS
1≈ 2.18B ARS2,181,083,409 ARS
2≈ 1.6B ARS1,601,475,666 ARS
3≈ 2.13B ARS2,130,380,573.9999998 ARS
4≈ 1.75B ARS1,747,214,446 ARS
5≈ 1.41B ARS1,409,192,436 ARS
6≈ 1.12B ARS1,116,806,714 ARS
7≈ 1.82B ARS1,819,509,605 ARS
8≈ 2.3B ARS2,298,896,703 ARS
9≈ 2.2B ARS2,196,897,476 ARS
10≈ 1.96B ARS1,959,616,400 ARS
11≈ 2.69B ARS2,688,118,594 ARS
12≈ 869.95M ARS869,951,804 ARS
13≈ 631.52M ARS631,517,503 ARS
14≈ 338.47M ARS338,466,799 ARS
15≈ 374.59M ARS374,594,241 ARS
16≈ 232.84M ARS232,837,284 ARS
17≈ 248.41M ARS248,413,251 ARS
18≈ 220.45M ARS220,445,106 ARS
19≈ 178.73M ARS178,732,798 ARS
20≈ 185.47M ARS185,467,468 ARS
21≈ 194.03M ARS194,029,063 ARS
22≈ 167.52M ARS167,523,998 ARS
23≈ 97.43M ARS97,428,522 ARS
24≈ 90.9M ARS90,901,746 ARS
25≈ 77.28M ARS77,280,313 ARS
26≈ 58.09M ARS58,094,847 ARS
27≈ 101.98M ARS101,979,807 ARS
28≈ 72.71M ARS72,714,117 ARS
29≈ 41.27M ARS41,274,603 ARS
30≈ 47.31M ARS47,307,820 ARS
31≈ 32.17M ARS32,167,684 ARS
32≈ 47.61M ARS47,608,861 ARS
Revenue & earnings

Gross profitLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Gross profit · ARS
Position in seriesValue · ARS
1≈ -328.86M ARS-328,857,952 ARS
2≈ -782M ARS-782,001,543 ARS
3≈ -609.92M ARS-609,923,024 ARS
4≈ 4.79M ARS4,792,521.000000509 ARS
5≈ 1.19B ARS1,187,925,196 ARS
6≈ 2.35B ARS2,353,419,502 ARS
7≈ 3.8B ARS3,801,288,943 ARS
8≈ 3.78B ARS3,783,006,516 ARS
Revenue & earnings

Gross profitFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Gross profit
Gross profitARS
2025≈ -609.92M ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Gross profit · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -609.92M ARS-609,923,024 ARS
2024≈ 3.8B ARS3,801,288,943 ARS
2023≈ 1.32B ARS1,322,074,316 ARS
2022≈ 636.03M ARS636,031,710 ARS
2021≈ 219.51M ARS219,509,674 ARS
2020≈ 187.37M ARS187,370,422 ARS
2019≈ 133.98M ARS133,976,056 ARS
2018≈ 80.46M ARS80,457,039 ARS
2017≈ 56.26M ARS56,255,158 ARS
2016≈ 59.84M ARS59,838,601 ARS
2015≈ 36.73M ARS36,732,479 ARS
2014≈ 31.99M ARS31,986,401 ARS
2013≈ 27.65M ARS27,652,976 ARS
2012≈ 27.36M ARS27,364,732 ARS
2011≈ 27.94M ARS27,941,065 ARS
2010≈ 20.34M ARS20,340,915 ARS
2009≈ 14.29M ARS14,293,489 ARS
2008≈ 13.41M ARS13,413,377 ARS
2007≈ 17.09M ARS17,089,215 ARS
2006≈ 17.22M ARS17,223,882 ARS
Revenue & earnings

Gross profitQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Gross profit · ARS
Position in seriesValue · ARS
1≈ 66.86M ARS66,855,941 ARS
2≈ -261.51M ARS-261,505,314 ARS
3≈ 290.92M ARS290,919,473 ARS
4≈ -425.13M ARS-425,128,052 ARS
5≈ -386.29M ARS-386,287,650 ARS
6≈ -89.43M ARS-89,426,794.9999999 ARS
7≈ 905.64M ARS905,635,018 ARS
8≈ 758M ARS758,004,623 ARS
9≈ 779.21M ARS779,206,656 ARS
10≈ 1.36B ARS1,358,442,646 ARS
11≈ 887.35M ARS887,352,591 ARS
12≈ 94.15M ARS94,145,223 ARS
13≈ 237.66M ARS237,662,375 ARS
14≈ 100.44M ARS100,443,951 ARS
15≈ 204.48M ARS204,478,647 ARS
16≈ 87.22M ARS87,217,621 ARS
17≈ 118.61M ARS118,613,471 ARS
18≈ 95.11M ARS95,112,944 ARS
19≈ 17.35M ARS17,352,924 ARS
20≈ 49.71M ARS49,708,086 ARS
21≈ 80.45M ARS80,453,682 ARS
22≈ 53.28M ARS53,275,901 ARS
23≈ 38.31M ARS38,308,966 ARS
24≈ 12.14M ARS12,141,559 ARS
25≈ 22.77M ARS22,765,428 ARS
26≈ -33.08M ARS-33,082,546 ARS
27≈ 51.72M ARS51,721,673 ARS
28≈ 38.93M ARS38,927,720 ARS
29≈ 10.35M ARS10,347,522 ARS
30≈ 16.08M ARS16,076,203 ARS
31≈ 9.04M ARS9,043,259 ARS
32≈ 18.65M ARS18,648,952 ARS
Revenue & earnings

EBITDALast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · EBITDA · ARS
Position in seriesValue · ARS
1≈ -3.26B ARS-3,255,151,380 ARS
2≈ -3.48B ARS-3,479,988,610 ARS
3≈ -2.98B ARS-2,980,632,830 ARS
4≈ -1.88B ARS-1,884,708,590 ARS
5≈ -577.61M ARS-577,613,920 ARS
6≈ 601.75M ARS601,749,100 ARS
7≈ 2.07B ARS2,072,574,960 ARS
8≈ 2.04B ARS2,041,505,030 ARS
Revenue & earnings

EBITDAFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

EBITDA
EBITDAARS
2025≈ -2.98B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · EBITDA · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -2.98B ARS-2,981,564,120 ARS
2024≈ 2.04B ARS2,042,886,490 ARS
2023≈ 177.99M ARS177,989,480 ARS
2022≈ 336.3M ARS336,303,310 ARS
2021≈ 31.45M ARS31,448,640 ARS
2020≈ 51.84M ARS51,842,580 ARS
2019≈ -9.26M ARS-9,264,480 ARS
2018≈ 8.61M ARS8,613,180 ARS
2017≈ 3.27M ARS3,271,500 ARS
2016≈ 17.87M ARS17,865,310 ARS
2015627,540 ARS
2014≈ 5.65M ARS5,645,540 ARS
2013≈ 7.28M ARS7,276,380 ARS
2012≈ 9.21M ARS9,205,240 ARS
2011≈ 11.62M ARS11,620,060 ARS
2010≈ 4.73M ARS4,729,800 ARS
2009837,650 ARS
2008361,510 ARS
2007≈ 4.37M ARS4,373,620 ARS
2006≈ 8.55M ARS8,547,680 ARS
Revenue & earnings

EBITDAQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · EBITDA · ARS
Position in seriesValue · ARS
1≈ -607.55M ARS-607,551,340 ARS
2≈ -936.88M ARS-936,876,200 ARS
3≈ -727.2M ARS-727,202,920 ARS
4≈ -983.52M ARS-983,520,910 ARS
5≈ -832.39M ARS-832,388,570 ARS
6≈ -437.52M ARS-437,520,430 ARS
7≈ 368.72M ARS368,721,340 ARS
8≈ 323.57M ARS323,573,740 ARS
9≈ 346.97M ARS346,974,460 ARS
10≈ 1.03B ARS1,033,305,429.9999999 ARS
11≈ 337.65M ARS337,651,400 ARS
12≈ -236.91M ARS-236,913,490 ARS
13≈ 88.6M ARS88,603,070 ARS
14≈ -11.35M ARS-11,351,500 ARS
15≈ 125.19M ARS125,190,800 ARS
16≈ 34.39M ARS34,393,530 ARS
17≈ 62.45M ARS62,448,690 ARS
18≈ 49.86M ARS49,855,770 ARS
19≈ -54.66M ARS-54,658,480 ARS
20≈ 15.99M ARS15,992,150 ARS
21≈ 40.31M ARS40,307,770 ARS
22≈ 22.23M ARS22,231,720 ARS
23≈ 18.97M ARS18,965,770 ARS
24—
25≈ 1.86M ARS1,862,830 ARS
26≈ -42.28M ARS-42,276,400 ARS
27≈ 35M ARS35,004,580 ARS
28≈ 15.59M ARS15,591,410 ARS
29≈ -3.98M ARS-3,981,460 ARS
30655,110 ARS
31≈ 1.49M ARS1,492,500 ARS
32≈ 3.06M ARS3,064,130 ARS
Revenue & earnings

Net incomeLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Net income · ARS
Position in seriesValue · ARS
1≈ -435.38M ARS-435,379,731 ARS
2≈ -4.49B ARS-4,491,273,023 ARS
3≈ -4.6B ARS-4,597,736,040 ARS
4≈ -4.43B ARS-4,425,665,932 ARS
5≈ -3.29B ARS-3,290,570,473 ARS
6≈ -2.33B ARS-2,325,124,388 ARS
7≈ -1.42B ARS-1,417,322,392 ARS
8≈ 181.79M ARS181,793,678 ARS
Revenue & earnings

Net incomeFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Net income
Net incomeARS
2025≈ -4.6B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Net income · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -4.6B ARS-4,597,736,040 ARS
2024≈ -1.42B ARS-1,417,322,392 ARS
2023≈ 562.94M ARS562,940,954 ARS
2022≈ -8.1M ARS-8,097,740.999999999 ARS
2021≈ -19.57M ARS-19,571,726 ARS
2020≈ -17.01M ARS-17,005,406 ARS
2019≈ -89.2M ARS-89,204,196 ARS
2018798,264 ARS
2017-72,315 ARS
2016≈ 10.16M ARS10,162,704 ARS
2015-727,460 ARS
2014≈ 8.35M ARS8,346,227.000000001 ARS
2013≈ -9.12M ARS-9,120,272 ARS
2012≈ 9.28M ARS9,284,004 ARS
2011≈ 6.96M ARS6,956,817 ARS
2010≈ 2.95M ARS2,950,858 ARS
2009982,002 ARS
2008≈ -1.37M ARS-1,367,615 ARS
2007≈ 1.78M ARS1,779,935 ARS
2006≈ 4.1M ARS4,099,993.0000000005 ARS
Revenue & earnings

Net incomeQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Net income · ARS
Position in seriesValue · ARS
1≈ 2.79B ARS2,788,161,200 ARS
2≈ -483.6M ARS-483,604,719 ARS
3≈ -1.35B ARS-1,353,545,983 ARS
4≈ -1.39B ARS-1,386,390,229 ARS
5≈ -1.27B ARS-1,267,732,092 ARS
6≈ -590.07M ARS-590,067,736 ARS
7≈ -1.18B ARS-1,181,475,875 ARS
8≈ -251.29M ARS-251,294,770 ARS
9≈ -302.29M ARS-302,286,007 ARS
10≈ 317.73M ARS317,734,260 ARS
11≈ 417.64M ARS417,640,195 ARS
12≈ 259.31M ARS259,309,323 ARS
13≈ -83.55M ARS-83,545,042 ARS
14≈ -30.46M ARS-30,463,522 ARS
15≈ -34.79M ARS-34,788,918 ARS
16≈ -20.79M ARS-20,793,848 ARS
17≈ 3.93M ARS3,933,829 ARS
18≈ 27.08M ARS27,083,581 ARS
19≈ 6M ARS5,999,229 ARS
20≈ -33.37M ARS-33,370,137.999999996 ARS
21≈ 16.75M ARS16,748,733.000000002 ARS
22≈ -6.58M ARS-6,580,576 ARS
23-50,425 ARS
24≈ -42.83M ARS-42,829,484 ARS
25≈ -4.79M ARS-4,790,251 ARS
26≈ -50.14M ARS-50,144,648 ARS
27≈ 20.65M ARS20,646,730 ARS
28≈ 3.32M ARS3,323,736 ARS
29≈ -2.05M ARS-2,051,219.0000000002 ARS
30≈ -3.21M ARS-3,208,225 ARS
31-928,385 ARS
32≈ 2.06M ARS2,060,509.9999999998 ARS
Revenue & earnings

Basic EPSFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Basic EPS
Basic EPSARS
2025≈ -107.95 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Basic EPS · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -107.95 ARS-107.9548 ARS
2024≈ -33.28 ARS-33.2787 ARS
2023≈ 13.22 ARS13.2178 ARS
2022≈ -0.19 ARS-0.1901 ARS
2021≈ -0.46 ARS-0.4595 ARS
2020≈ -0.399 ARS-0.3993 ARS
2019≈ -2.09 ARS-2.0945 ARS
20180.0187 ARS
2017-0.002 ARS
20160.239 ARS
2015-0.017 ARS
20140.2 ARS
2013-0.215 ARS
20120.219 ARS
20110.16 ARS
20100.0696 ARS
20090.023 ARS
2008-0.032 ARS
20070.0466 ARS
2006≈ 0.104 ARS0.1044 ARS
Revenue & earnings

Diluted EPSLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Diluted EPS · ARS
Position in seriesValue · ARS
1≈ -10.22 ARS-10.2227 ARS
2≈ -105.46 ARS-105.455 ARS
3≈ -107.95 ARS-107.9548 ARS
4≈ -103.91 ARS-103.9146 ARS
5≈ -77.26 ARS-77.2626 ARS
6≈ -54.59 ARS-54.5939 ARS
7≈ -33.28 ARS-33.2787 ARS
8≈ 4.27 ARS4.2685 ARS
Revenue & earnings

Diluted EPSFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Diluted EPS
Diluted EPSARS
2025≈ -107.95 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Diluted EPS · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ -107.95 ARS-107.9548 ARS
2024≈ -33.28 ARS-33.2787 ARS
2023≈ 13.22 ARS13.2178 ARS
2022≈ -0.19 ARS-0.1901 ARS
2021≈ -0.46 ARS-0.4595 ARS
2020≈ -0.399 ARS-0.3993 ARS
2019≈ -2.09 ARS-2.0945 ARS
20180.0187 ARS
2017-0.002 ARS
20160.239 ARS
2015-0.017 ARS
20140.2 ARS
2013-0.215 ARS
20120.219 ARS
20110.16 ARS
2010—
2009—
2008—
2007—
2006—
Revenue & earnings

Diluted EPSQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Diluted EPS · ARS
Position in seriesValue · ARS
1≈ 65.47 ARS65.466 ARS
2≈ -11.36 ARS-11.355 ARS
3≈ -31.78 ARS-31.7812 ARS
4≈ -32.55 ARS-32.5524 ARS
5≈ -29.77 ARS-29.7663 ARS
6≈ -13.85 ARS-13.8548 ARS
7≈ -27.74 ARS-27.741 ARS
8≈ -5.9 ARS-5.9004 ARS
9≈ -7.1 ARS-7.0977 ARS
10≈ 7.46 ARS7.4604 ARS
11≈ 9.81 ARS9.8062 ARS
12≈ 6.09 ARS6.0886 ARS
13≈ -1.96 ARS-1.9616 ARS
14≈ -0.715 ARS-0.7153 ARS
15≈ -0.817 ARS-0.8168 ARS
16≈ -0.488 ARS-0.4882 ARS
170.0924 ARS
18≈ 0.636 ARS0.6359 ARS
19≈ 0.141 ARS0.1409 ARS
20≈ -0.784 ARS-0.7835 ARS
21≈ 0.393 ARS0.3933 ARS
22≈ -0.155 ARS-0.1545 ARS
23-0.0012 ARS
24≈ -1.01 ARS-1.0056 ARS
25≈ -0.113 ARS-0.1125 ARS
26≈ -1.18 ARS-1.1774 ARS
27≈ 0.485 ARS0.4848 ARS
280.078 ARS
29-0.0482 ARS
30-0.075 ARS
31-0.02 ARS
320.048 ARS
All metric groups

Balance sheet

Balance sheet
Total assets≈ 7.75B ARS7,745,454,535 ARSFiscal year 2025Period end:
Total liabilities≈ 8.27B ARS8,271,645,463.999999 ARSFiscal year 2025Period end:
Total equity≈ -526.19M ARS-526,190,929 ARSFiscal year 2025Period end:

How to read this group

The balance sheet describes one date. Read assets, liabilities and equity together; debt and total liabilities differ.

Definitions in the guide
ROSE · Balance sheet
IndicatorIndicator and periodPeriodValue
Total assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 7.75B ARS7,745,454,535 ARS
Total assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 22.67B ARS22,666,208,558 ARS
Total assetsPeriod not specifiedPeriod not specified≈ 22.67B ARS22,666,208,558 ARS
Current assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 5.73B ARS5,732,979,805 ARS
Current assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 8.01B ARS8,010,019,676 ARS
Current assetsPeriod not specifiedPeriod not specified≈ 8.01B ARS8,010,019,676 ARS
Total liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 8.27B ARS8,271,645,463.999999 ARS
Total liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 14.73B ARS14,734,353,625 ARS
Current liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 6.61B ARS6,605,344,948 ARS
Current liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 4.47B ARS4,471,936,871 ARS
Total equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -526.19M ARS-526,190,929 ARS
Total equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 7.93B ARS7,931,854,933 ARS
Total debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1.45B ARS1,450,004,478 ARS
Total debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.07B ARS3,067,876,474 ARS
Total debtPeriod not specifiedPeriod not specified≈ 3.07B ARS3,067,876,474 ARS
Net debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 737.74M ARS737,740,781 ARS
Net debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.08B ARS2,081,445,626.0000002 ARS
Net debtPeriod not specifiedPeriod not specified≈ 2.08B ARS2,081,445,626.0000002 ARS
Book value per shareLatest available figureLatest available figure≈ 180.08 ARS180.08431 ARS
Book value per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -18.79 ARS-18.78793 ARS
Book value per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 180.08 ARS180.08431 ARS
Cash & equivalentsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 712.26M ARS712,263,697 ARS
Cash & equivalentsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 986.43M ARS986,430,848 ARS
Cash & short-term investmentsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 712.26M ARS712,263,697 ARS
Cash & short-term investmentsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 986.43M ARS986,430,848 ARS
Cash per shareLatest available figureLatest available figure≈ 23.16 ARS23.16138152944631 ARS
Cash per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 16.72 ARS16.7239409323409 ARS
Cash per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 23.16 ARS23.16138152944631 ARS
GoodwillFiscal year 2025Period end: Fiscal year 2025Period end: 0 ARS
GoodwillQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0 ARS
GoodwillPeriod not specifiedPeriod not specified0 ARS
Long-term debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 931.02M ARS931,022,364 ARS
Long-term debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.65B ARS2,653,575,618 ARS
Shareholders’ equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -800.17M ARS-800,168,048 ARS
Shareholders’ equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 7.67B ARS7,669,694,429 ARS
Short-term debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 518.98M ARS518,982,114 ARS
Short-term debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 414.3M ARS414,300,856 ARS
Tangible book value per shareLatest available figureLatest available figure≈ 180.08 ARS180.084310263113 ARS
Tangible book value per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -18.79 ARS-18.7879337765807 ARS
Tangible book value per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 180.08 ARS180.084310263113 ARS
Total debt per shareLatest available figureLatest available figure≈ 72.03 ARS72.03369363761674 ARS
Total debt per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 34.05 ARS34.04608341522957 ARS
Total debt per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 72.03 ARS72.03369363761674 ARS
Working capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 3.54B ARS3,538,082,805 ARS
Working capital per shareLatest available figureLatest available figure≈ 83.07 ARS83.0741312434894 ARS
Working capital per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -20.48 ARS-20.4831204853125 ARS
Working capital per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 83.07 ARS83.0741312434894 ARS

Choose an indicator to explore its history.

Total assets

Resources recorded on the balance sheet: cash, property and rights. Their accounting amount is not the company’s stock-market value.

Total debt

Borrowed financing the company must repay. It is part of liabilities, not every obligation of the business.

Balance sheet

Total assetsFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Total assets
Total assetsARS
2025≈ 7.75B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Total assets · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 7.75B ARS7,745,454,535 ARS
2024≈ 7.54B ARS7,542,016,849 ARS
2023≈ 5.04B ARS5,042,761,206 ARS
2022≈ 1.35B ARS1,347,992,247 ARS
2021≈ 747.29M ARS747,291,579 ARS
2020≈ 675.64M ARS675,640,386 ARS
2019≈ 496.94M ARS496,938,633 ARS
2018≈ 366.76M ARS366,755,730 ARS
2017≈ 213.52M ARS213,524,591 ARS
2016≈ 197.86M ARS197,856,838 ARS
2015≈ 166.17M ARS166,170,337 ARS
2014≈ 140.76M ARS140,755,331 ARS
2013≈ 125.89M ARS125,888,965 ARS
2012≈ 114.9M ARS114,898,394 ARS
2011≈ 86.45M ARS86,445,777 ARS
2010≈ 73.43M ARS73,425,376 ARS
2009≈ 64.48M ARS64,482,445 ARS
2008≈ 57.44M ARS57,441,037 ARS
2007≈ 53.83M ARS53,829,858 ARS
2006≈ 48.52M ARS48,519,748 ARS
Balance sheet

Total assetsQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Total assets · ARS
Position in seriesValue · ARS
1≈ 22.67B ARS22,666,208,558 ARS
2≈ 9.11B ARS9,111,264,833 ARS
3≈ 7.75B ARS7,745,454,535 ARS
4≈ 8.09B ARS8,087,115,875 ARS
5≈ 7.4B ARS7,398,742,640 ARS
6≈ 7.56B ARS7,559,323,356 ARS
7≈ 7.54B ARS7,542,016,849 ARS
8≈ 7.52B ARS7,517,109,872 ARS
9≈ 7B ARS6,998,952,897 ARS
10≈ 6.57B ARS6,565,284,289 ARS
11≈ 5.04B ARS5,042,761,206 ARS
12≈ 2.71B ARS2,709,266,764 ARS
13≈ 1.91B ARS1,905,596,600 ARS
14≈ 1.65B ARS1,652,524,770 ARS
15≈ 1.35B ARS1,347,992,247 ARS
16≈ 1.21B ARS1,209,149,751 ARS
17≈ 970.22M ARS970,219,483 ARS
18≈ 848.62M ARS848,619,091 ARS
19≈ 747.29M ARS747,291,579 ARS
20≈ 760.55M ARS760,546,667 ARS
21≈ 730.19M ARS730,188,613 ARS
22≈ 705.44M ARS705,442,543 ARS
23≈ 524.51M ARS524,505,932 ARS
24≈ 496.94M ARS496,938,633 ARS
25≈ 405.37M ARS405,369,641 ARS
26≈ 366.76M ARS366,755,730 ARS
27≈ 334.86M ARS334,859,412 ARS
28≈ 289.21M ARS289,205,277 ARS
29≈ 240.03M ARS240,032,873 ARS
30≈ 213.52M ARS213,524,591 ARS
31≈ 214.34M ARS214,342,578 ARS
32≈ 205.53M ARS205,528,523 ARS
Balance sheet

Total debtFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Total debt
Total debtARS
2025≈ 1.45B ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Total debt · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 1.45B ARS1,450,004,478 ARS
2024≈ 1.74B ARS1,740,294,248 ARS
2023≈ 1.03B ARS1,033,846,858.0000001 ARS
2022≈ 344.94M ARS344,938,917 ARS
2021≈ 190.98M ARS190,975,143 ARS
2020≈ 155.12M ARS155,124,786 ARS
2019≈ 125.07M ARS125,067,925 ARS
2018≈ 93.84M ARS93,837,234 ARS
2017≈ 42.83M ARS42,832,357 ARS
2016≈ 32.66M ARS32,661,935.999999996 ARS
2015≈ 34.12M ARS34,121,149 ARS
2014≈ 20.37M ARS20,368,077 ARS
2013≈ 23.34M ARS23,338,384 ARS
2012≈ 21.39M ARS21,390,455 ARS
2011≈ 1.04M ARS1,040,840 ARS
2010467,394 ARS
2009730,847 ARS
2008346,023 ARS
2007≈ 3.41M ARS3,406,283 ARS
2006350,312 ARS
Balance sheet

Total debtQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Total debt · ARS
Position in seriesValue · ARS
1≈ 3.07B ARS3,067,876,474 ARS
2≈ 1.99B ARS1,987,485,755 ARS
3≈ 1.45B ARS1,450,004,478 ARS
4≈ 2.6B ARS2,597,003,403 ARS
5≈ 2.3B ARS2,304,467,163 ARS
6≈ 2.14B ARS2,136,550,726 ARS
7≈ 1.74B ARS1,740,294,248 ARS
8≈ 1.22B ARS1,223,734,045 ARS
9≈ 1.32B ARS1,323,418,105 ARS
10≈ 1B ARS1,003,379,235 ARS
11≈ 1.03B ARS1,033,846,858.0000001 ARS
12≈ 573.74M ARS573,741,089 ARS
13≈ 453.78M ARS453,781,813 ARS
14≈ 375.77M ARS375,769,428 ARS
15≈ 344.94M ARS344,938,917 ARS
16≈ 277.37M ARS277,367,211 ARS
17≈ 202.8M ARS202,796,461 ARS
18≈ 185.64M ARS185,639,585 ARS
19≈ 190.98M ARS190,975,143 ARS
20≈ 175.75M ARS175,749,689 ARS
21≈ 159.65M ARS159,648,317 ARS
22≈ 164.77M ARS164,768,304 ARS
23≈ 130.26M ARS130,257,891 ARS
24≈ 125.07M ARS125,067,925 ARS
25≈ 87.14M ARS87,137,959 ARS
26≈ 93.84M ARS93,837,234 ARS
27≈ 87.79M ARS87,785,680 ARS
28≈ 74.33M ARS74,328,733 ARS
29≈ 55.06M ARS55,064,125 ARS
30≈ 42.83M ARS42,832,357 ARS
31≈ 46.05M ARS46,045,202 ARS
32≈ 37.41M ARS37,413,212 ARS
All metric groups

Cash flow

Cash flow
Operating cash flow≈ 409.89M ARS409,886,740 ARSFiscal year 2025Period end:
Fixed-asset investment≈ -12.13M ARS-12,134,976 ARSFiscal year 2025Period end:
Free cash flow≈ 397.75M ARS397,751,760 ARSFiscal year 2025Period end:

How to read this group

Free cash flow depends on its definition. We preserve the received amount and sign without recalculating it from other rows.

Definitions in the guide
ROSE · Cash flow
IndicatorIndicator and periodPeriodValue
Operating cash flowLast 12 monthsLast 12 months≈ 867.08M ARS867,084,615 ARS
Operating cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 409.89M ARS409,886,740 ARS
Operating cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 1.17B ARS1,170,481,414 ARS
Operating cash flowHalf-yearHalf-year≈ 140.48M ARS140,481,048 ARS
Investing cash flowLast 12 monthsLast 12 months≈ 125.72M ARS125,717,247 ARS
Investing cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -12.13M ARS-12,134,976 ARS
Investing cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 127.17M ARS127,172,816 ARS
Investing cash flowHalf-yearHalf-year≈ 135.43M ARS135,429,834 ARS
Financing cash flowLast 12 monthsLast 12 months≈ -1.26B ARS-1,262,503,716 ARS
Financing cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -839.33M ARS-839,331,035 ARS
Financing cash flowQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -522.3M ARS-522,298,791.00000006 ARS
Financing cash flowHalf-yearHalf-year≈ -121.73M ARS-121,731,149.00000006 ARS
Capital expenditure · source signLast 12 monthsLast 12 months-0 ARS
Capital expenditure · source signFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -12.13M ARS-12,134,976 ARS
Capital expenditure · source signQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: -0 ARS
Capital expenditure · source signHalf-yearHalf-year0 ARS
Free cash flowFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 397.75M ARS397,751,760 ARS
Capital expenditure per shareLatest available figureLatest available figure0 ARS
Capital expenditure per shareLast 12 monthsLast 12 months0 ARS
Capital expenditure per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.285 ARS0.284929054638277 ARS
Capital expenditure per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0 ARS
Free cash flow per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 9.34 ARS9.339205364519136 ARS
Operating cash flow per shareLatest available figureLatest available figure≈ 20.36 ARS20.3591337670008 ARS
Operating cash flow per shareLast 12 monthsLast 12 months≈ 20.36 ARS20.3591337670008 ARS
Operating cash flow per shareFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 9.62 ARS9.62413451307735 ARS
Operating cash flow per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 27.48 ARS27.4828860611421 ARS

Choose an indicator to explore its history.

Cash flow

Free cash flowLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Free cash flow · ARS
Position in seriesValue · ARS
1—
2—
3≈ 397.75M ARS397,751,760 ARS
4≈ -477.59M ARS-477,591,640 ARS
5≈ -370.1M ARS-370,098,150 ARS
6≈ 514.08M ARS514,077,630 ARS
7≈ 537.19M ARS537,190,060 ARS
8≈ 631.97M ARS631,967,450 ARS
Cash flow

Free cash flowFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Free cash flow
Free cash flowARS
2025≈ 397.75M ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Free cash flow · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
2025≈ 397.75M ARS397,751,760 ARS
2024≈ 537.19M ARS537,190,060 ARS
2023≈ 99.16M ARS99,155,570 ARS
2022≈ 22.72M ARS22,715,500 ARS
2021≈ 27.82M ARS27,823,020 ARS
2020≈ 41.51M ARS41,505,640 ARS
2019≈ 12.05M ARS12,051,470 ARS
2018≈ -23.57M ARS-23,565,030 ARS
2017≈ -10.99M ARS-10,987,410 ARS
201683,240 ARS
2015≈ -11.25M ARS-11,247,380 ARS
2014≈ 5.04M ARS5,043,730 ARS
2013≈ -11.55M ARS-11,550,050 ARS
2012≈ -12.98M ARS-12,983,660 ARS
2011≈ 1.01M ARS1,007,960 ARS
2010≈ 1.33M ARS1,331,420 ARS
2009≈ -3.71M ARS-3,711,980 ARS
2008≈ 5.62M ARS5,616,080 ARS
2007≈ -1.19M ARS-1,192,900 ARS
2006≈ -2.07M ARS-2,073,080 ARS
Cash flow

Free cash flowQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Free cash flow · ARS
Position in seriesValue · ARS
1—
2—
3≈ 806.69M ARS806,694,370 ARS
4≈ -89.8M ARS-89,803,390 ARS
5≈ -841.33M ARS-841,333,940 ARS
6≈ 522.19M ARS522,194,719.99999994 ARS
7≈ -68.65M ARS-68,649,040 ARS
8≈ 17.69M ARS17,690,100 ARS
9≈ 42.84M ARS42,841,850 ARS
10≈ 545.31M ARS545,307,150 ARS
11≈ 26.13M ARS26,128,350 ARS
12≈ 47.55M ARS47,545,120 ARS
13≈ 22.65M ARS22,647,140 ARS
14≈ 2.83M ARS2,834,970 ARS
15≈ -10.29M ARS-10,288,510 ARS
16≈ -25.16M ARS-25,161,720 ARS
17≈ 17.16M ARS17,156,380 ARS
18≈ 41.01M ARS41,009,360 ARS
19≈ 4.73M ARS4,732,640 ARS
20≈ 2.03M ARS2,034,910 ARS
21≈ 23.54M ARS23,542,070 ARS
22≈ -2.49M ARS-2,486,600 ARS
23-842,040 ARS
24—
25≈ 14.05M ARS14,054,720 ARS
26≈ 30.63M ARS30,632,540 ARS
27≈ -29.27M ARS-29,267,200 ARS
28≈ -22.85M ARS-22,845,830 ARS
29≈ -2.08M ARS-2,084,550.0000000002 ARS
30≈ 3.47M ARS3,471,530 ARS
31≈ -9.95M ARS-9,947,840 ARS
32≈ -9.42M ARS-9,422,620 ARS
Cash flow

Capital expenditure · unspecified calculation basisLast 12 months

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
10
20
3≈ 12.13M12,134,976
4≈ 9.58M9,582,084
5≈ 9.03M9,034,170
6≈ 10M9,996,879
7≈ 10.37M10,373,915
8≈ 42.13M42,134,470
Cash flow

Capital expenditure · unspecified calculation basisFinancial year

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
1≈ 12.13M12,134,976
2≈ 10.37M10,373,915
3≈ 53.02M53,015,050
4≈ 26.54M26,535,207
5≈ 2.14M2,144,456
6≈ 2.08M2,078,262
7≈ 7.23M7,225,196
8≈ 1.51M1,506,854
9≈ 1.95M1,952,816
10≈ 15.76M15,756,562
11≈ 2.45M2,452,492
12≈ 4.2M4,197,411
13≈ 4.29M4,293,015
140
150
16≈ 3.82M3,815,241
17≈ 4.77M4,768,275
18≈ 2.74M2,739,778
19≈ 1.25M1,246,168
20≈ 1.97M1,973,839
Cash flow

Capital expenditure · unspecified calculation basisQuarter

The source does not provide dates for individual observations. Row numbers identify their original position, not years or quarters. Every value is retained, including missing observations. “—” does not mean zero.

This series’ unit is not confirmed; values are shown without conversion.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Capital expenditure · unspecified calculation basis · unit not specified
Position in seriesValue · unit not specified
10
20
3≈ 4.49M4,489,813
4≈ 5.22M5,222,774
5≈ 2.28M2,280,425
6141,964
7≈ 1.94M1,936,921
8≈ 4.67M4,674,860
9≈ 3.24M3,243,134
10519,000
11≈ 33.7M33,697,476
12≈ 2.72M2,724,463
13≈ 10.96M10,957,866
14≈ 5.64M5,635,245
15≈ 16.02M16,016,006.999999998
16≈ 7.13M7,134,981
17≈ 1.58M1,576,566
18≈ 1.81M1,807,653
19478,746
20718,688
21340,273
22606,749
23922,679
24—
25≈ 4.78M4,775,793
26935,083
2784,593
2888,075
29399,103
30630,318
31≈ 1.22M1,218,518
3274,856
All metric groups

Profitability & efficiency

Profitability & efficiency
Net margin≈ -5.68%-5.68369416072432%Last 12 months
Return on equity (ROE)≈ -450.26%-450.260772215527%Fiscal year 2025Period end:
Return on assets (ROA)≈ -60.15%-60.1503796738031%Fiscal year 2025Period end:

How to read this group

Margins relate profit to revenue; ROE relates profit to equity. Compare similar businesses and periods.

Definitions in the guide
ROSE · Profitability & efficiency
IndicatorIndicator and periodPeriodValue
After-tax marginPeriod not specifiedPeriod not specified≈ -5.68%-5.68369416072432%
Asset turnoverLatest available figureLatest available figure≈ 0.51×0.509573692273918×
Asset turnoverFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.838×0.837757142322707×
EBITDA marginLast 12 monthsLast 12 months≈ -42.49%-42.4945939680865%
EBITDA marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -46.56%-46.56079134384%
Free cash flow marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 6.21%6.211383005241259%
Gross marginLast 12 monthsLast 12 months≈ -4.29%-4.2930983883817%
Gross marginReported figure 1Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -9.52%-9.5246982836203%
Gross marginPeriod not specifiedPeriod not specified≈ -4.29%-4.2930983883817%
Gross marginReported figure 2Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -9.52%-9.524698283620307%
Net marginLast 12 monthsLast 12 months≈ -5.68%-5.68369416072432%
Net marginFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -71.8%-71.7993039212227%
Net marginPeriod not specifiedPeriod not specified≈ -5.68%-5.68369416072432%
Net margin before discontinued operationsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -71.8%-71.79930392122273%
Operating marginReported figure 1Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -49.55%-49.55311452849298%
Operating marginLast 12 monthsLast 12 months≈ -44.49%-44.4862663170747%
Operating marginReported figure 2Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -49.55%-49.553114528493%
Operating marginPeriod not specifiedPeriod not specified≈ -44.49%-44.4862663170747%
Pre-tax marginLast 12 monthsLast 12 months≈ -42.55%-42.5475920403139%
Pre-tax marginPeriod not specifiedPeriod not specified≈ -42.55%-42.5475920403139%
Return on assets (ROA)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -60.15%-60.1503796738031%
Return on assets (ROA)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -2.9%-2.896261019236%
Return on assets (ROA)Period not specifiedPeriod not specified≈ -2.9%-2.896261019236%
Return on capital employed (ROCE)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -117.71%-117.71363542398234%
Return on capital employed (ROCE)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -31.76%-31.764258585737686%
Return on common equityLast 12 monthsLast 12 months≈ -9.5%-9.49715799825327%
Return on common equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -450.26%-450.260772215527%
Return on equity (ROE)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -450.26%-450.260772215527%
Return on equity (ROE)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -9.5%-9.49715799825327%
Return on equity (ROE)Period not specifiedPeriod not specified≈ -9.5%-9.49715799825327%
Return on invested capital (ROIC)Last 12 monthsLast 12 months≈ -6.8%-6.8036432559214095%
Return on invested capital (ROIC)Fiscal year 2025Period end: Fiscal year 2025Period end: ≈ -244.14%-244.141632103573%
Return on invested capital (ROIC)Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -6.8%-6.80364325592141%
Return on invested capital (ROIC)Period not specifiedPeriod not specified≈ -6.8%-6.8036432559214095%
Return on tangible assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -60.15%-60.15037967380309%
Return on tangible assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -2.9%-2.8962610192359977%
Return on tangible equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -450.26%-450.26077221552674%
Return on tangible equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -9.5%-9.497157998253266%
Return on total capitalFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -111.39%-111.393626678871%
Return on total capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ -45.36%-45.3580329775008%

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Debt & liquidity

Debt & liquidity
Current ratio≈ 1.79×1.79117458655198×Quarter 2 · fiscal 2026Period end:
Quick ratio≈ 0.956×0.956181222666459×Quarter 2 · fiscal 2026Period end:
Debt / equity≈ 0.4×0.399999830814642×Quarter 2 · fiscal 2026Period end:

How to read this group

Liquidity concerns near-term obligations; leverage concerns business financing. Read both alongside cash flow.

Definitions in the guide
ROSE · Debt & liquidity
IndicatorIndicator and periodPeriodValue
Assets / equityFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -9.68×-9.67978483314795×
Assets / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 2.96×2.95529486445985×
Cash and short-term investments / current liabilitiesFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.108×0.10783141571064549×
Cash and short-term investments / current liabilitiesQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.221×0.22058246269013576×
Cash and short-term investments / debtFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.491×0.49121482575173125×
Cash and short-term investments / debtQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.322×0.3215353865645896×
Current ratioLatest available figureLatest available figure≈ 1.79×1.79117458655198×
Current ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.868×0.867930418491749×
Current ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 1.79×1.79117458655198×
Current ratioPeriod not specifiedPeriod not specified≈ 1.79×1.79117458655198×
Debt / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.187×0.187207151168179×
Debt / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.135×0.135350227019649×
Debt / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.4×0.399999830814642×
Debt / equityPeriod not specifiedPeriod not specified≈ 0.4×0.399999830814642×
Debt / revenueLast 12 monthsLast 12 months≈ 0.4×0.40049801034714044×
Debt / revenueFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.226×0.2264360356865026×
Debt / total capitalFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 2.23×2.2313376275319×
Debt / total capitalQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.286×0.285714199475041×
EBITDA interest coverageLast 12 monthsLast 12 months≈ -1.44×-1.436769673123776×
EBITDA interest coverageFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -1.59×-1.5883189011219605×
EBITDA less CapEx interest coverageLast 12 monthsLast 12 months≈ -1.44×-1.436769673123776×
EBITDA less CapEx interest coverageFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -1.59×-1.5947833643934937×
Effective interest rate on debtLast 12 monthsLast 12 months≈ 52.51%52.51264126576992%
Long-term debt / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.12×0.120202418049569×
Long-term debt / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.117×0.11707187866068694×
Long-term debt / equityQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.346×0.3459819217785945×
Quick ratioLatest available figureLatest available figure≈ 0.956×0.956181222666459×
Quick ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 0.473×0.473136803543663×
Quick ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.956×0.956181222666459×
Quick ratioPeriod not specifiedPeriod not specified≈ 0.956×0.956181222666459×
Shareholders’ equity / assetsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -0.103×-0.10330808145399566×
Shareholders’ equity / assetsQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 0.338×0.33837571066966093×
Sloan ratioLast 12 monthsLast 12 months≈ -6.3%-6.300928491615444%
Sloan ratioFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -64.5%-64.49573464573955%
Zmijewski scoreLast 12 monthsLast 12 months≈ -0.55-0.5504679252470721
Zmijewski scoreFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 4.414.411213878127797

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Growth

Growth
Revenue · year-on-year change≈ 15.29%15.287276542960182%Last 12 months
Net income · year-on-year change≈ 86.77%86.76886775188663%Last 12 months
Revenue · 5-year compound annual growth (CAGR)≈ 62.88%62.87730604532831%Period not specified

How to read this group

YoY compares with the same period a year earlier; QoQ with the previous quarter. These bases are not interchangeable.

Definitions in the guide
ROSE · Growth
IndicatorIndicator and periodPeriodValue
Capital expenditure · source sign · year-on-year changeLast 12 monthsLast 12 months-100%
Capital expenditure · source sign · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 16.98%16.97585723422642%
Capital expenditure · source sign · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: -100%
Diluted EPS · year-on-year changeLast 12 monthsLast 12 months≈ 86.77%86.76888947563245%
Diluted EPS · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -224.4%-224.39608518361598%
Diluted EPS change over 5 yearsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -26,936.01%-26,936.013022789888%
Diluted EPS growthFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -224.4%-224.39608518361604%
EBITDA · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 35.15%35.15137432245584%
EBITDA · year-on-year changeLast 12 monthsLast 12 months≈ -463.55%-463.55140817935967%
EBITDA · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -245.95%-245.9485945300857%
EBITDA · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 27.01%27.011090505483516%
Free cash flow · 5-year compound annual growth (CAGR)Period not specifiedPeriod not specified≈ 57.15%57.14515621517102%
Free cash flow · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -25.96%-25.956976940340258%
Gross profit · year-on-year changeLast 12 monthsLast 12 months≈ -127.68%-127.68338891264665%
Gross profit · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -116.05%-116.04516344707659%
Net income · year-on-year changeLast 12 monthsLast 12 months≈ 86.77%86.76886775188663%
Net income · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -224.4%-224.3959219124508%
Revenue · 5-year compound annual growth (CAGR)Period not specifiedPeriod not specified≈ 62.88%62.87730604532831%
Revenue · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 36.19%36.19210427640678%
Revenue · year-on-year changeLast 12 monthsLast 12 months≈ 15.29%15.287276542960182%
Revenue · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -22.61%-22.614429775628647%
Revenue · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 54.78%54.7754127314944%
Revenue change over 5 yearsFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 1,046.31%1,046.3121296669449%
Total assets · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 148.77%148.7712625354219%
Total assets · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ 2.7%2.6973910304506137%
Total assets · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 206.35%206.35216902205968%
Total debt · quarter-on-quarter changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 54.36%54.35967107095065%
Total debt · year-on-year changeFiscal year 2025Period end: Fiscal year 2025Period end: ≈ -16.68%-16.680499308298582%
Total debt · year-on-year changeQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 33.13%33.127367716803526%

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Dividends & buybacks

Dividends & buybacks
Dividend yield0%Latest available figure
Latest dividend per shareNot availablePeriod not specified
Payment dateNot availablePeriod not specified

How to read this group

Separate past payments, upcoming payments and estimates. Yield depends on the price and dividend period.

Definitions in the guide
ROSE · Dividends & buybacks
IndicatorIndicator and periodPeriodValue
Buyback yieldPeriod not specifiedPeriod not specified-0%
Common dividend per share · primary issueFiscal year 2025Period end: Fiscal year 2025Period end: 0 ARS
Common dividend per share · primary issueQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0 ARS
Common dividend per share · primary issueHalf-yearHalf-year0 ARS
Consecutive years of dividend growthPeriod not specifiedPeriod not specified0
Consecutive years paying dividendsPeriod not specifiedPeriod not specified0
Dividend payout ratioLast 12 monthsLast 12 months-0%
Dividend payout ratio, %Quarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0%
Dividend per shareQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0 ARS
Dividend yieldLatest available figureLatest available figure0%
Dividend yieldFiscal year 2025Period end: Fiscal year 2025Period end: 0%
Dividend yieldQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0%
Dividends paid · source signPeriod not specifiedPeriod not specified-0 ARS
Dividends paid · source signLast 12 monthsLast 12 months-0 ARS
Dividends paid · source signFiscal year 2025Period end: Fiscal year 2025Period end: -0 ARS
Dividends paid · source signQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: -0 ARS
Dividends paid · source signHalf-yearHalf-year0 ARS
Share buyback ratioFiscal year 2025Period end: Fiscal year 2025Period end: 0%
Share buyback ratioQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: 0%

Choose an indicator to explore its history.

Financial year

Common dividend per share · primary issue

Dividends & buybacks

Common dividend per share · primary issueFinancial year

Years come from the same instrument’s source record. Every period and missing value is retained; “—” is not zero. Historical figures are not restated for inflation here.

Common dividend per share · primary issue
Common dividend per share · primary issueARS
20250 ARS

Newest first

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Common dividend per share · primary issue · fiscal year (FY) · historical series · ARS
Fiscal yearValue · ARS
20250 ARS
20240 ARS
20230 ARS
20220 ARS
20210 ARS
20200 ARS
20190 ARS
20180 ARS
20170 ARS
20160 ARS
20150 ARS
20140 ARS
20130 ARS
20120 ARS
20110 ARS
20100 ARS
20090 ARS
20080 ARS
20070 ARS
2006≈ 0.0183 ARS0.01827811573562 ARS
All metric groups

Shares & workforce

Shares & workforce
Shares outstanding≈ 42.58M42,583,400Period not specified
Shares in public circulationNot availableLatest available figure
Number of employeesNot availablePeriod not specified

How to read this group

Shares outstanding, free float and voting rights are different concepts. Check the share class and date.

Definitions in the guide
ROSE · Shares & workforce
IndicatorIndicator and periodPeriodValue
Diluted shares · FQQuarter 2 · fiscal 2026Period end: Quarter 2 · fiscal 2026Period end: ≈ 42.59M42,589,465
Shares outstandingLatest available figureLatest available figure≈ 42.58M42,583,400
Shares outstandingPeriod not specifiedPeriod not specified≈ 42.58M42,583,400
Shares outstanding · fundamental fieldPeriod not specifiedPeriod not specified≈ 42.58M42,583,400
Shares outstanding · provider-calculated fieldPeriod not specifiedPeriod not specified≈ 42.58M42,583,412.17081851

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Analyst expectations

Analyst expectations

How to read this group

An estimate is not a reported result. Before comparing, check the horizon, currency and per-share basis.

Definitions in the guide

Browse this group’s reported values or history.

No figures available yet

Missing data does not mean zero. You can explore another group.

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Price & market risk

Price & market risk
Beta · 1 year≈ 0.5780.5776786Period not specified
52-week price high357 ARSPeriod not specified
52-week price low116 ARSPeriod not specified

How to read this group

Beta describes historical sensitivity to an index; the 52-week range describes observed prices. Neither guarantees future prices.

Definitions in the guide
ROSE · Price & market risk
IndicatorIndicator and periodPeriodValue
52-week price highPeriod not specifiedPeriod not specified357 ARS
52-week price lowPeriod not specifiedPeriod not specified116 ARS
Beta · 1 yearPeriod not specifiedPeriod not specified≈ 0.5780.5776786
Beta · 3 yearsPeriod not specifiedPeriod not specified≈ 0.5260.5260218
Beta · 5 yearsPeriod not specifiedPeriod not specified≈ 0.5490.5487519
Date of 52-week highPeriod not specifiedPeriod not specifiedNov 21, 2025
Date of 52-week lowPeriod not specifiedPeriod not specifiedOct 22, 2025

Choose an indicator to explore its history.

No historical series are published for this selection.

All metric groups

Periods & calendar

Periods & calendar
Fiscal period endDec 31, 2025Financial year
Fiscal period endJun 30, 2026Quarter
Next earnings release · expected dateNot availablePeriod not specified

How to read this group

Fiscal period end, publication and retrieval are different dates. A fiscal year can end outside December.

Definitions in the guide

Additional information

ROSE · Periods & calendar
IndicatorIndicator and periodPeriodValue
Fiscal periodLatest available figureLatest available figure2026-Q2
Fiscal periodFinancial yearFinancial year2025
Fiscal period endLatest available figureLatest available figureJun 30, 2026
Fiscal period endFinancial yearFinancial yearDec 31, 2025
Fiscal period endQuarterQuarterJun 30, 2026

Choose an indicator to explore its history.

Financial year

Historical fiscal-year identifiers

Periods & calendar

Historical fiscal-year identifiersFinancial year

Published fiscal-year identifiers, in their original order.

Scroll the table vertically or sideways. With a keyboard, focus it and use the arrow keys.

ROSE · Historical fiscal-year identifiers · Fiscal year
Position in seriesFiscal year
12025
22024
32023
42022
52021
62020
72019
82018
92017
102016
112015
122014
132013
142012
152011
162010
172009
182008
192007
202006
All metric groups

Additional information

Additional information

How to read this group

These fields have no verified classification. Retain the code, unit and context when interpreting them.

Definitions in the guide

Browse this group’s reported values or history.

No figures available yet

Missing data does not mean zero. You can explore another group.

Choose an indicator to explore its history.

No historical series are published for this selection.

Financial dataUpdated: Oct 03, 2026 · ARS

A view of the market.
With full transparency.

Closing prices and daily history from BYMA Open Data. These are not real-time quotes.

Quote sourceBYMA Open DataLatest available sessionOct 02, 2026Last fetchedOct 3, 2026, 04:27 AM GMT-3CurrencyARSSettlementT+1 · 24hsCoverage133 / 258

Daily history is kept as supplied by BYMA. Symbols without data show no quote. Dates may differ between stocks. Corporate-action adjustments are not independently verified.

Financial data

Financial statements, multiples and estimates. Availability varies by instrument. Profiles and shareholders show their sources and dates.

Last fetched: Oct 03, 2026

La Plata is independent. Commercial data publication requires reviewing BYMA terms.